Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
entecavir, Quantity: 0.5 mg
Arrotex Pharmaceuticals Pty Ltd
Entecavir
Tablet
Excipient Ingredients: lactose monohydrate; magnesium stearate; macrogol 8000; microcrystalline cellulose; hyprolose; copovidone; hypromellose; crospovidone; titanium dioxide
Oral
30
(S4) Prescription Only Medicine
Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.
Visual Identification: White colored, triangular shaped film coated tablets, engraved 'APO' on one side and '0.5' over 'ENT' on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2016-03-10